Skip to content
2000
image of Unlocking the Therapeutic Potential of Piperine - From Ethnopharmacology to Nanodelivery Strategies

Abstract

Herbs have long been esteemed for their therapeutic properties and utilized to treat a broad spectrum of diseases. Notably, piperine is a naturally occurring alkaloid abundantly found in numerous plants, with four isomeric variants. Contemporary literature revealed that piperine has significant pharmacological activities, including cardioprotective, neuroprotective, gastroprotective, hepatoprotective, nephroprotective, anti-allergic, anti-cancer, anti-inflammatory, anti-diabetic, anti-microbial, and many more. Piperine's diverse pharmacological profile not only reveals its versatility in experimental studies but also highlights its effectiveness in numerous clinical outcomes. However, despite the therapeutic benefits evident from numerous animal and human investigations, the clinical relevance of piperine faces numerous challenges because of its low aqueous solubility, stability, and limited bioavailability. To address these constraints, nanoformulations like nanoparticles, liposomes, micelles, gold nanogels, nanosuspensions, nanoemulsions, and self-nanoemulsifying drug delivery systems have emerged as innovative approaches that play a crucial role in optimizing the bioavailability and efficacy of piperine. By utilizing these novel drug delivery systems, piperine’s therapeutic potential can be harnessed, paving the way for its application in diverse clinical conditions. This manuscript seeks to advance the current understanding of piperine's therapeutic potential, elucidating its mechanistic insights against numerous disorders and exploring various nanoformulation strategies to optimize its delivery and efficacy.

© 2025 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/cnanom/10.2174/0124681873431538251104034810
2025-11-24
2026-02-28

  • From This Site

    /content/journals/cnanom/10.2174/0124681873431538251104034810
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. Prasathkumar M. Anisha S. Dhrisya C. Becky R. Sadhasivam S. Therapeutic and pharmacological efficacy of selective Indian medicinal plants - A review. Phytomedicine Plus 2021 1 2 100029 10.1016/j.phyplu.2021.100029
    [Google Scholar]
  2. Wadhwa K. Pahwa R. Kumar M. Mechanistic insights into the pharmacological significance of silymarin. Molecules 2022 27 16 5327 10.3390/molecules27165327 36014565
    [Google Scholar]
  3. Ekor M. The growing use of herbal medicines: Issues relating to adverse reactions and challenges in monitoring safety. Front. Pharmacol. 2014 4 177 10.3389/fphar.2013.00177 24454289
    [Google Scholar]
  4. El-Dahiyat F. Rashrash M. Abuhamdah S. Abu Farha R. Babar Z.U.D. Herbal medicines: A cross-sectional study to evaluate the prevalence and predictors of use among Jordanian adults. J. Pharm. Policy Pract. 2020 13 1 2 10.1186/s40545‑019‑0200‑3 31988754
    [Google Scholar]
  5. Stojanović-Radić Z. Pejčić M. Dimitrijević M. Aleksić A. Piperine-a major principle of black pepper: A review of its bioactivity and studies. Appl. Sci. 2019 9 4270 10.3390/app9204270
    [Google Scholar]
  6. Lee J.G. Chae Y. Shin Y. Kim Y.J. Chemical composition and antioxidant capacity of black pepper pericarp. Appl Biol Chem 2020 63 1 9 10.3839/jabc.2020.001
    [Google Scholar]
  7. Dzoyem J.P. McGaw L.J. Kuete V. Bakowsky U. Anti inflammatory and anti nociceptive activities of African medicinal spices and vegetables. Medicinal Spices and Vegetables from Africa. Amsterdam, Netherlands Elsevier 2017 239 270 10.1016/B978‑0‑12‑809286‑6.00009‑1
    [Google Scholar]
  8. Ajaiyeoba E.O. Ekundayo O. Essential oil constituents ofAframomum melegueta (Roscoe) K. Schum. seeds (alligator pepper) from Nigeria. Flavour Fragrance J. 1999 14 2 109 111 10.1002/(SICI)1099‑1026(199903/04)14:2<109:AID‑FFJ775>3.0.CO;2‑M
    [Google Scholar]
  9. Yadav S.S. Singh M.K. Hussain S. Dwivedi P. Khattri S. Singh K. Therapeutic spectrum of piperine for clinical practice: A scoping review. Crit. Rev. Food Sci. Nutr. 2023 63 22 5813 5840 10.1080/10408398.2021.2024792 34996326
    [Google Scholar]
  10. Namjoyan F. Hejazi H. Ramezani Z. Evaluation of drying process on the composition of black pepper ethanolic extract by high performance liquid chromatography with diode array detector. Jundishapur J. Nat. Pharm. Prod. 2012 7 4 163 167 10.17795/jjnpp‑5177 24624176
    [Google Scholar]
  11. Kumari S. Gupta S. Yogi B. Panday D. Kaur R. Characterization and quantification of piperine: A bioactive ingredient of black pepper. World J. Pharm. Res. 2021 10 595 614 10.20959/wjpr20211‑19481
    [Google Scholar]
  12. Tiwari A. Mahadik K.R. Gabhe S.Y. Piperine: A comprehensive review of methods of isolation, purification, and biological properties. Med Drug Discov 2020 7 100027 10.1016/j.medidd.2020.100027
    [Google Scholar]
  13. Al-Khayri J.M. Upadhya V. Pai S.R. Naik P.M. Al-Mssallem M.Q. Alessa F.M. Comparative quantification of the phenolic compounds, piperine content, and total polyphenols along with the antioxidant activities in the Piper trichostachyon and P. nigrum. Molecules 2022 27 18 5965 10.3390/molecules27185965 36144701
    [Google Scholar]
  14. Rameshkumar K.B. Aravind A.P.A. Mathew P.J. Comparative phytochemical evaluation and antioxidant assay of Piper longum L. and Piper chaba hunter used in Indian traditional systems of medicine. J. Herbs Spices Med. Plants 2011 17 4 351 360 10.1080/10496475.2011.632116
    [Google Scholar]
  15. Mohapatra M. Basak U.C. Evaluation of piperine content from roots of Piper longum Linn., originated from different sources with comparison of zonal variation in Odisha, India. Int. J. Pharma Res. Rev. 2015 4 1 8
    [Google Scholar]
  16. Khan M. Comparative physicochemical evaluation of fruits and anti depressant potential of volatile oils of fruits of local piper species. Orient. J. Chem. 2015 31 1 541 545 10.13005/ojc/310167
    [Google Scholar]
  17. Singh I. Choudhary A. Piperine and derivatives: Trends in structure-activity relationships. Curr. Top. Med. Chem. 2015 15 17 1722 1734 10.2174/1568026615666150427123213 25915609
    [Google Scholar]
  18. Wu N. Yin X. Cui C. Structural modification, total synthesis, and biological activity of natural product piperine: A review. J. Funct. Foods 2025 128 106827 10.1016/j.jff.2025.106827
    [Google Scholar]
  19. Singh N.K. Kumar P. Gupta D.K. Singh S. Singh V.K. UV-spectrophotometric method development for estimation of piperine in Chitrakadi Vati. Pharm. Lett. 2011 3 178 182
    [Google Scholar]
  20. Gupta V. Jain U. Estimation of piperine by UV-spectrophotometric method in herbal formulation, Pippli churna. Int. J. Res. Pharm. Biomed. Sci. 2011 2 550 553 10.5555/20113293560
    [Google Scholar]
  21. Vyas A. Jain V. Singh D. Singh M. Shukla S. Pandey R. TLC densitometric method for the estimation of piperine in ayurvedic formulation Trikatu Churna. Orient. J. Chem. 2011 27 301 304
    [Google Scholar]
  22. Stępniowska A. Cieplińska P. Fac W. Górska J. Selected alkaloids used in the cosmetics industry. J. Cosmet. Sci. 2021 72 2 229 245 [PMID: 35361327
    [Google Scholar]
  23. Haq I.U. Imran M. Nadeem M. Tufail T. Gondal T.A. Mubarak M.S. Piperine: A review of its biological effects. Phytother. Res. 2021 35 2 680 700 10.1002/ptr.6855 32929825
    [Google Scholar]
  24. Lin F. Hu Y. Zhang Y. Zhao L. Zhong D. Liu J. Predicting food-drug interactions between piperine and CYP3A4 substrate drugs using PBPK modeling. Int. J. Mol. Sci. 2024 25 20 10955 10.3390/ijms252010955 39456737
    [Google Scholar]
  25. Reen R.K. Jamwal D.S. Taneja S.C. Impairment of UDP-glucose dehydrogenase and glucuronidation activities in liver and small intestine of rat and guinea pig in vitro by piperine. Biochem. Pharmacol. 1993 46 2 229 238 10.1016/0006‑2952(93)90408‑O 8347144
    [Google Scholar]
  26. Azam S. Park J.Y. Kim I.S. Choi D.K. Piperine and its metabolite’s pharmacology in neurodegenerative and neurological diseases. Biomedicines 2022 10 1 154 10.3390/biomedicines10010154 35052833
    [Google Scholar]
  27. Correia A.O. Cruz A.A.P. de Aquino A.T.R. Neuroprotective effects of piperine, an alkaloid from the Piper genus, on the Parkinson’s disease model in rats. J Neurol Ther 2015 1 1 1 8 10.14312/2397‑1304.2015‑1
    [Google Scholar]
  28. Roshanbakhsh H. Elahdadi Salmani M. Dehghan S. Nazari A. Javan M. Pourabdolhossein F. Piperine ameliorated memory impairment and myelin damage in lysolecethin induced hippocampal demyelination. Life Sci. 2020 253 117671 10.1016/j.lfs.2020.117671 32335165
    [Google Scholar]
  29. Kaushik P. Ali M. Salman M. Tabassum H. Parvez S. Harnessing the mitochondrial integrity for neuroprotection: Therapeutic role of piperine against experimental ischemic stroke. Neurochem. Int. 2021 149 105138 10.1016/j.neuint.2021.105138 34284077
    [Google Scholar]
  30. Sudjarwo S.A. Eraiko K. Sudjarwo G.W. Koerniasari. Protective effects of piperine on lead acetate induced-nephrotoxicity in rats. Iran. J. Basic Med. Sci. 2017 20 11 1227 1231 10.22038/IJBMS.2017.9487 29299200
    [Google Scholar]
  31. Mohammadi M. Najafi H. Mohamadi Yarijani Z. Vaezi G. Hojati V. Piperine pretreatment attenuates renal ischemia-reperfusion induced liver injury. Heliyon 2019 5 8 e02180 e0 10.1016/j.heliyon.2019.e02180 31463384
    [Google Scholar]
  32. Mohammadi M. Najafi H. Mohamadi Yarijani Z. Vaezi G. Hojati V. Protective effect of piperine in ischemia-reperfusion induced acute kidney injury through inhibition of inflammation and oxidative stress. J. Tradit. Complement. Med. 2020 10 6 570 576 10.1016/j.jtcme.2019.07.002 33134133
    [Google Scholar]
  33. Li L. Zhao K. Luo J. Piperine improves hyperuricemic nephropathy by inhibiting URAT1/GLUT9 and the AKT-mTOR pathway. J. Agric. Food Chem. 2024 72 12 6565 6574 10.1021/acs.jafc.3c07655 38498316
    [Google Scholar]
  34. Dhivya V. Priya L.B. Chirayil H.T. Sathiskumar S. Huang C.Y. Padma V.V. Piperine modulates isoproterenol induced myocardial ischemia through antioxidant and anti-dyslipidemic effect in male Wistar rats. Biomed. Pharmacother. 2017 87 705 713 10.1016/j.biopha.2017.01.002 28088738
    [Google Scholar]
  35. Yan J. Xu S.C. Kong C.Y. Piperine alleviates doxorubicin-induced cardiotoxicity via activating PPAR-γ in mice. PPAR Res. 2019 2019 1 11 10.1155/2019/2601408 31933619
    [Google Scholar]
  36. Wang D. Zhang L. Huang J. Cardiovascular protective effect of black pepper (Piper nigrum L.) and its major bioactive constituent piperine. Trends Food Sci. Technol. 2021 117 34 45 10.1016/j.tifs.2020.11.024
    [Google Scholar]
  37. Shu G. Yusuf A. Dai C. Sun H. Deng X. Piperine inhibits AML-12 hepatocyte EMT and LX-2 HSC activation and alleviates mouse liver fibrosis provoked by CCl 4: Roles in the activation of the Nrf2 cascade and subsequent suppression of the TGF-β1/Smad axis. Food Funct. 2021 12 22 11686 11703 10.1039/D1FO02657G 34730139
    [Google Scholar]
  38. Naseema U. Venkata G. Rao S. Pazhanivel N. Pandiyan V. Sriram P. Chemotherapeutic effect of piperine solid lipid nanoparticles against benzo(a)pyrene: Induced lung cancer in mice. Pharma Innov J 2018 7 198 201
    [Google Scholar]
  39. Zadorozhna M. Tataranni T. Mangieri D. Piperine: Role in prevention and progression of cancer. Mol. Biol. Rep. 2019 46 5 5617 5629 10.1007/s11033‑019‑04927‑z 31273611
    [Google Scholar]
  40. He Q. Xu J.Y. Gu J. Piperine is capable of improving pancreatic β-cell apoptosis in high fat diet and streptozotocin induced diabetic mice. J. Funct. Foods 2022 88 104890 10.1016/j.jff.2021.104890
    [Google Scholar]
  41. Mounithaa N. Gayathri R. Jayaraman S. Priya V.V. Kavitha S. Effect of piperine on an Nrf2/Keap 1 signalling mechanism in adipose tissue of high fat diet and sucrose-induced experimental diabetic rats. J Adv Zool 2023 44 232 239 10.53555/JAZ.V44IS5.713
    [Google Scholar]
  42. Tasleem F. Azhar I. Ali S.N. Perveen S. Mahmood Z.A. Analgesic and anti-inflammatory activities of Piper nigrum L. Asian Pac. J. Trop. Med. 2014 7 S461 S468 10.1016/S1995‑7645(14)60275‑3 25312168
    [Google Scholar]
  43. Chung H.Y. Jung H.J. Kim D.H. Bang E. Ha S. Anti-inflammatory and antioxidant activities of piperine on t-BHP-induced in Ac2F cells. SDRP J Food Sci Tech 2019 4 4 777 787 10.25177/JFST.4.4.RA.530
    [Google Scholar]
  44. Dhargawe N. Mahakalkar S. Mohod B. Raj J. Evaluation of analgesic, anti-inflammatory, and antipyretic activity of piperine: An experimental study. Pharmacognosy Res. 2020 12 2 176 10.4103/pr.pr_94_19
    [Google Scholar]
  45. Gupta R.A. Motiwala M.N. Dumore N.G. Danao K.R. Ganjare A.B. Effect of piperine on inhibition of FFA induced TLR4 mediated inflammation and amelioration of acetic acid induced ulcerative colitis in mice. J. Ethnopharmacol. 2015 164 239 246 10.1016/j.jep.2015.01.039 25683300
    [Google Scholar]
  46. Afroz M. Bhuia M.S. Rahman M.A. Anti-diarrheal effect of piperine possibly through the interaction with inflammation inducing enzymes: In vivo and in silico studies. Eur. J. Pharmacol. 2024 965 176289 10.1016/j.ejphar.2023.176289 38158111
    [Google Scholar]
  47. Aswar U. Shintre S. Chepurwar S. Aswar M. Antiallergic effect of piperine on ovalbumin-induced allergic rhinitis in mice. Pharm. Biol. 2015 53 9 1358 1366 10.3109/13880209.2014.982299 25868617
    [Google Scholar]
  48. Bui T.T. Piao C.H. Hyeon E. The protective role of Piper nigrum fruit extract in an ovalbumin-induced allergic rhinitis by targeting of NFκBp65 and STAT3 signalings. Biomed. Pharmacother. 2019 109 1915 1923 10.1016/j.biopha.2018.11.073 30551446
    [Google Scholar]
  49. Manjunath G.B. Awasthi S.P. Zahid M.S.H. Piperine, an active ingredient of white pepper, suppresses the growth of multidrug-resistant toxigenic Vibrio cholerae and other pathogenic bacteria. Lett. Appl. Microbiol. 2022 74 4 472 481 10.1111/lam.13646 34978719
    [Google Scholar]
  50. Alves F.S. Cruz J.N. de Farias Ramos I.N. Evaluation of antimicrobial activity and cytotoxicity effects of extracts of Piper nigrum L. and piperine. Separations 2022 10 1 21 10.3390/separations10010021
    [Google Scholar]
  51. BrahmaNaidu P Nemani H Meriga B Mehar SK Potana S Ramgopalrao S Mitigating efficacy of piperine in the physiological derangements of high fat diet induced obesity in Sprague Dawley rats. Chem. Biol. Interact. 2014 221 42 51 10.1016/j.cbi.2014.07.008 25087745
    [Google Scholar]
  52. Meriga B. Parim B. Chunduri V.R. Antiobesity potential of Piperonal: Promising modulation of body composition, lipid profiles and obesogenic marker expression in HFD-induced obese rats. Nutr. Metab. 2017 14 1 72 10.1186/s12986‑017‑0228‑9 29176994
    [Google Scholar]
  53. Du Y. Chen Y. Fu X. Effects of piperine on lipid metabolism in high-fat diet induced obese mice. J. Funct. Foods 2020 71 104011 10.1016/j.jff.2020.104011
    [Google Scholar]
  54. Tripathi A.K. Ray A.K. Mishra S.K. Molecular and pharmacological aspects of piperine as a potential molecule for disease prevention and management: Evidence from clinical trials. Beni. Suef Univ. J. Basic Appl. Sci. 2022 11 1 16 10.1186/s43088‑022‑00196‑1 35127957
    [Google Scholar]
  55. Ferreira F.M. Gomes S.V. Carvalho L.C.F. Potential of piperine for neuroprotection in sepsis-associated encephalopathy. Life Sci. 2024 337 122353 10.1016/j.lfs.2023.122353 38104862
    [Google Scholar]
  56. Hsieh T.Y. Chang Y. Wang S.J. Piperine provides neuroprotection against kainic acid-induced neurotoxicity via maintaining NGF signalling pathway. Molecules 2022 27 9 2638 10.3390/molecules27092638 35565989
    [Google Scholar]
  57. Li R. Lu Y. Zhang Q. Piperine promotes autophagy flux by P2RX4 activation in SNCA/α-synuclein-induced Parkinson disease model. Autophagy 2022 18 3 559 575 10.1080/15548627.2021.1937897 34092198
    [Google Scholar]
  58. Fu M. Sun Z. Zuo H. Neuroprotective effect of piperine on primarily cultured hippocampal neurons. Biol. Pharm. Bull. 2010 33 4 598 603 10.1248/bpb.33.598 20410592
    [Google Scholar]
  59. Khalili-Fomeshi M. Azizi M.G. Esmaeili M.R. Piperine restores streptozotocin-induced cognitive impairments: Insights into oxidative balance in cerebrospinal fluid and hippocampus. Behav. Brain Res. 2018 337 131 138 10.1016/j.bbr.2017.09.031 28939403
    [Google Scholar]
  60. Adefegha S.A. Oyediran J.A. Oboh G. Piperine abates cognitive dysfunction via modulation of key enzymes relevant to neurodegeneration in scopolamine-induced rats. Comp. Clin. Pathol. 2023 32 3 451 460 10.1007/s00580‑023‑03456‑3
    [Google Scholar]
  61. Beghi E. The epidemiology of epilepsy. Neuroepidemiology 2020 54 2 185 191 10.1159/000503831 31852003
    [Google Scholar]
  62. da Cruz G.M.P. Felipe C.F.B. Scorza F.A. Piperine decreases pilocarpine-induced convulsions by GABAergic mechanisms. Pharmacol. Biochem. Behav. 2013 104 144 153 10.1016/j.pbb.2013.01.002 23313550
    [Google Scholar]
  63. Zou Y. Gong P. Zhao W. Quantitative iTRAQ-based proteomic analysis of piperine protected cerebral ischemia/reperfusion injury in rat brain. Neurochem. Int. 2019 124 51 61 10.1016/j.neuint.2018.12.010 30579855
    [Google Scholar]
  64. Zhang Y. Yang M. Yuan Q. Piperine ameliorates ischemic stroke-induced brain injury in rats by regulating the PI3K/AKT/mTOR pathway. J. Ethnopharmacol. 2022 295 115309 10.1016/j.jep.2022.115309 35597410
    [Google Scholar]
  65. Lu J. Dai X. Xi S. Piperine protects against cerebral ischemic injury by regulating the Caspase-1-mediated pyroptosis pathway. Front. Pharmacol. 2025 16 1601873 10.3389/fphar.2025.1601873 40786035
    [Google Scholar]
  66. Yang W. Chen Y.H. Liu H. Qu H.D. Neuroprotective effects of piperine on the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson’s disease mouse model. Int. J. Mol. Med. 2015 36 5 1369 1376 10.3892/ijmm.2015.2356 26648012
    [Google Scholar]
  67. Wang L. Cai X. Shi M. Identification and optimization of piperine analogues as neuroprotective agents for the treatment of Parkinson’s disease via the activation of Nrf2/keap1 pathway. Eur. J. Med. Chem. 2020 199 112385 10.1016/j.ejmech.2020.112385 32402936
    [Google Scholar]
  68. Liu J. Chen M. Wang X. Piperine induces autophagy by enhancing protein phosphotase 2A activity in a rotenone-induced Parkinson’s disease model. Oncotarget 2016 7 38 60823 60843 10.18632/oncotarget.11661 27572322
    [Google Scholar]
  69. Wang C. Cai Z. Wang W. Piperine attenuates cognitive impairment in an experimental mouse model of sporadic Alzheimer’s disease. J. Nutr. Biochem. 2019 70 147 155 10.1016/j.jnutbio.2019.05.009 31207354
    [Google Scholar]
  70. Ghasemi A. Saadinezhad A. Halalkhor S. Piperine improves learning deficit through modulation of Wnt/β-catenin signaling pathway: Involvement of the dorsal hippocampus serotonin-1A receptors. Eur. J. Pharmacol. 2025 1003 177922 10.1016/j.ejphar.2025.177922 40639477
    [Google Scholar]
  71. Salman M. Tabassum H. Parvez S. Piperine mitigates behavioral impairments and provides neuroprotection against 3-nitropropinoic acid-induced Huntington disease-like symptoms. Nutr. Neurosci. 2022 25 1 100 109 10.1080/1028415X.2020.1721645 32093571
    [Google Scholar]
  72. Mao K. Lei D. Zhang H. You C. Anticonvulsant effect of piperine ameliorates memory impairment, inflammation and oxidative stress in a rat model of pilocarpine-induced epilepsy. Exp. Ther. Med. 2017 13 2 695 700 10.3892/etm.2016.4001 28352353
    [Google Scholar]
  73. Chen C.Y. Li W. Qu K.P. Chen C.R. Piperine exerts anti-seizure effects via the TRPV1 receptor in mice. Eur. J. Pharmacol. 2013 714 1-3 288 294 10.1016/j.ejphar.2013.07.041 23911889
    [Google Scholar]
  74. Zhang H. Wu C. Yu D. Su H. Chen Y. Ni W. Piperine attenuates the inflammation, oxidative stress, and pyroptosis to facilitate recovery from spinal cord injury via autophagy enhancement. Phytother. Res. 2023 37 2 438 451 10.1002/ptr.7625 36114802
    [Google Scholar]
  75. Di Cesare M. Perel P. Taylor S. The heart of the world. Glob. Heart 2024 19 1 11 10.5334/gh.1288 38273998
    [Google Scholar]
  76. Ullah A. Kumar M. Sayyar M. Revolutionizing cardiac care: A comprehensive narrative review of cardiac rehabilitation and the evolution of cardiovascular medicine. Cureus 2023 15 10 46469 10.7759/cureus.46469 37927717
    [Google Scholar]
  77. Ma Z.G. Yuan Y.P. Zhang X. Xu S.C. Wang S.S. Tang Q.Z. Piperine attenuates pathological cardiac fibrosis via PPAR-γ/AKT pathways. EBioMedicine 2017 18 179 187 10.1016/j.ebiom.2017.03.021 28330809
    [Google Scholar]
  78. Dutta M. Ghosh A.K. Mishra P. Protective effects of piperine against copper-ascorbate induced toxic injury to goat cardiac mitochondria in vitro. Food Funct. 2014 5 9 2252 2267 10.1039/C4FO00355A 25059674
    [Google Scholar]
  79. Guo X. Hu S. Liu J.J. Piperine protects against pyroptosis in myocardial ischaemia/reperfusion injury by regulating the miR‐383/RP105/AKT signalling pathway. J. Cell. Mol. Med. 2021 25 1 244 258 10.1111/jcmm.15953 33219747
    [Google Scholar]
  80. Hussain S Ashafaq M Alshahrani S Cardioprotective effects of nano-piperine against cypermethrin toxicity through oxidative stress, histopathological and immunohistochemical studies in male Wistar rats. Nat Prod Commun 2023 18 3 1934578X231154029 10.1177/1934578X231154029
    [Google Scholar]
  81. Tasleem F. Bin S. Mahmood Z. Azhar I. Mahmood Z.A. Acute liver injury induced by carbon tetrachloride and demonstration of hepatoprotective and in-vitro anti-oxidant capacity by Piper nigrum extracts and pure compound-piperine in Swiss Albino rats. J Xi’an Shiyou Univ 2023 19 1111 1138
    [Google Scholar]
  82. Rao P. Kolla S. Elshaari F. Effect of piperine on liver function of CF-1 albino mice. Infect. Disord. Drug Targets 2015 15 2 131 134 10.2174/1871526515666150724114616 26205799
    [Google Scholar]
  83. Yesmin S. Zahan R. Hossain M.M. Antioxidant activity and hepatoprotective potential of piper chaba roots against paracetamol-induced liver injury. Pharmacol. Pharm. 2019 10 11 484 497 10.4236/pp.2019.1011040
    [Google Scholar]
  84. Abdelhamid A.M. Selim A. Zaafan M.A. The hepatoprotective effect of piperine against thioacetamide-induced liver fibrosis in mice: The involvement of miR-17 and TGF-β/Smads pathways. Front. Mol. Biosci. 2021 8 754098 10.3389/fmolb.2021.754098 34778375
    [Google Scholar]
  85. Wali A.F. Ali S. Rashid S. Attenuation of oxidative damage-associated hepatotoxicity by piperine in CCl4-induced liver fibrosis. J. King Saud Univ. Sci. 2021 33 8 101629 10.1016/j.jksus.2021.101629
    [Google Scholar]
  86. Biswas S. Mukherjee P.K. Kar A. Bannerjee S. Charoensub R. Duangyod T. Optimized piperine-phospholipid complex with enhanced bioavailability and hepatoprotective activity. Pharm. Dev. Technol. 2021 26 1 69 80 10.1080/10837450.2020.1835956 33059499
    [Google Scholar]
  87. Coelho A.M. Queiroz I.F. Perucci L.O. Piperine as therapeutic agent in paracetamol-induced hepatotoxicity in mice. Pharmaceutics 2022 14 9 1800 10.3390/pharmaceutics14091800 36145547
    [Google Scholar]
  88. Hussain S. Jali A.M. Alshahrani S. Hepatoprotective and antioxidant effects of nanopiperine against cypermethrin via mitigation of oxidative stress, inflammations and gene expression using qRT-PCR. Int. J. Mol. Sci. 2023 24 20 15361 10.3390/ijms242015361 37895045
    [Google Scholar]
  89. Umapathy V.R. Dhanavel A. Kesavan R. Natarajan P.M. S B, P V. Anticancer potential of the principal constituent of Piper nigrum, piperine: A comprehensive review. Cureus 2024 16 2 54425 10.7759/cureus.54425 38405638
    [Google Scholar]
  90. Mitra S. Anand U. Jha N.K. Anticancer applications and pharmacological properties of piperidine and piperine: A comprehensive review on molecular mechanisms and therapeutic perspectives. Front. Pharmacol. 2022 12 772418 10.3389/fphar.2021.772418 35069196
    [Google Scholar]
  91. Buranrat B. Junking M. Piperine suppresses growth and migration of human breast cancer cells through attenuation of Rac1 expression. Asian Pac. J. Trop. Biomed. 2022 12 1 39 46 10.4103/2221‑1691.333211
    [Google Scholar]
  92. Zare Z Nayerpour Dizaj T Lohrasbi A The effect of piperine on MMP-9, VEGF, and E-cadherin expression in breast cancer MCF-7 cell line. Basic Clin Cancer Res 2021 12 3 112 119 10.18502/bccr.v12i3.5767
    [Google Scholar]
  93. Song L. Wang Y. Zhen Y. Piperine inhibits colorectal cancer migration and invasion by regulating STAT3/Snail-mediated epithelial-mesenchymal transition. Biotechnol. Lett. 2020 42 10 2049 2058 10.1007/s10529‑020‑02923‑z 32500474
    [Google Scholar]
  94. de Almeida G.C. Oliveira L.F.S. Predes D. Piperine suppresses the Wnt/β-catenin pathway and has anti-cancer effects on colorectal cancer cells. Sci. Rep. 2020 10 1 11681 10.1038/s41598‑020‑68574‑2 32669593
    [Google Scholar]
  95. Cardoso L.P. de Sousa S.O. Gusson-Zanetoni J.P. Piperine reduces neoplastic progression in cervical cancer cells by downregulating the cyclooxygenase 2 pathway. Pharmaceuticals 2023 16 1 103 10.3390/ph16010103 36678600
    [Google Scholar]
  96. Wojtowicz K. Sterzyńska K. Świerczewska M. Nowicki M. Zabel M. Januchowski R. Piperine targets different drug resistance mechanisms in human ovarian cancer cell lines leading to increased sensitivity to cytotoxic drugs. Int. J. Mol. Sci. 2021 22 8 4243 10.3390/ijms22084243 33921897
    [Google Scholar]
  97. Guo L. Yang Y. Sheng Y. Wang J. Ruan S. Han C. Mechanism of piperine in affecting apoptosis and proliferation of gastric cancer cells via ROS‐mitochondria‐associated signalling pathway. J. Cell. Mol. Med. 2021 25 20 9513 9522 10.1111/jcmm.16891 34464498
    [Google Scholar]
  98. Yoo E.S. Choo G.S. Kim S.H. Antitumor and apoptosis-inducing effects of piperine on human melanoma cells. Anticancer Res. 2019 39 4 1883 1892 10.21873/anticanres.13296 30952729
    [Google Scholar]
  99. Xia Y. Khoi P.N. Yoon H.J. Piperine inhibits IL-1β-induced IL-6 expression by suppressing p38 MAPK and STAT3 activation in gastric cancer cells. Mol. Cell. Biochem. 2015 398 1-2 147 156 10.1007/s11010‑014‑2214‑0 25234193
    [Google Scholar]
  100. Sriwiriyajan S. Tedasen A. Lailerd N. Anticancer and cancer prevention effects of piperine-free Piper nigrum extract on N-nitrosomethylurea-induced mammary tumorigenesis in rats. Cancer Prev. Res. 2016 9 1 74 82 10.1158/1940‑6207.CAPR‑15‑0127 26511488
    [Google Scholar]
  101. Gunasekaran V. Elangovan K. Niranjali Devaraj S. Targeting hepatocellular carcinoma with piperine by radical-mediated mitochondrial pathway of apoptosis: An in vitro and in vivo study. Food Chem. Toxicol. 2017 105 106 118 10.1016/j.fct.2017.03.029 28341137
    [Google Scholar]
  102. Tiwari A. Modi S.J. Gabhe S.Y. Kulkarni V.M. Evaluation of piperine against cancer stem cells (CSCs) of hepatocellular carcinoma: Insights into epithelial-mesenchymal transition (EMT). Bioorg. Chem. 2021 110 104776 10.1016/j.bioorg.2021.104776 33743225
    [Google Scholar]
  103. Marques da Fonseca L. Jacques da Silva L.R. Santos dos Reis J. Piperine inhibits TGF-β signaling pathways and disrupts EMT-related events in human lung adenocarcinoma cells. Medicines 2020 7 4 19 10.3390/medicines7040019 32276474
    [Google Scholar]
  104. Han E.J. Choi E.Y. Jeon S.J. Piperine induces apoptosis and autophagy in HSC-3 human oral cancer cells by regulating PI3K signaling pathway. Int. J. Mol. Sci. 2023 24 18 13949 10.3390/ijms241813949 37762259
    [Google Scholar]
  105. Siddiqui S. Ahamad M.S. Jafri A. Afzal M. Arshad M. Piperine triggers apoptosis of human oral squamous carcinoma through cell cycle arrest and mitochondrial oxidative stress. Nutr. Cancer 2017 69 5 791 799 10.1080/01635581.2017.1310260 28426244
    [Google Scholar]
  106. Si L. Yang R. Lin R. Yang S. Piperine functions as a tumor suppressor for human ovarian tumor growth via activation of JNK/p38 MAPK-mediated intrinsic apoptotic pathway. Biosci. Rep. 2018 38 3 BSR20180503 10.1042/BSR20180503 29717031
    [Google Scholar]
  107. Chang W.L. Peng J.Y. Hong C.L. Piperine induces apoptosis and cell cycle arrest via multiple oxidative stress mechanisms and regulation of PI3K/Akt and MAPK signaling in colorectal cancer cells. Antioxidants 2025 14 7 892 10.3390/antiox14070892 40722996
    [Google Scholar]
  108. Jan I. Ali T. Ali R. Khan N.J. Andrabi K.I. Bader G.N. Molecular dynamics and experimental evaluation of piperine as a potential mTOR inhibitor in colon cancer cells. In Silico Pharmacol. 2025 13 1 52 10.1007/s40203‑025‑00339‑z 40162129
    [Google Scholar]
  109. Wu C. Qian Y. Jiang J. Li D. Feng L. Piperine inhibits the proliferation of colorectal adenocarcinoma by regulating ARL3-mediated endoplasmic reticulum stress. Biomolecules and Biomedicine 2025 25 2 391 405 10.17305/bb.2024.10525 38972051
    [Google Scholar]
  110. Chen H. Sheng H. Zhao Y. Zhu G. Piperine inhibits cell proliferation and induces apoptosis of human gastric cancer cells by downregulating phosphatidylinositol 3-kinase (PI3K)/Akt pathway. Med. Sci. Monit. 2021 27 e928403 e1 10.12659/MSM.928403 33382670
    [Google Scholar]
  111. Shin S.A. Lee H.N. Choo G.S. Induction of apoptosis and inhibition of growth in human gastric cancer by piperine. J Korean Soc Food Sci Nutrit 2016 45 11 1589 1594 10.3746/jkfn.2016.45.11.1589
    [Google Scholar]
  112. Raja W. Dubey A. Bandhe L.K. Pandey S. Anticarcinogenic activity of Piper nigrum extract and its active component piperine against 7, 12-dimethylbenz (a) anthracene induced mouse skin. Eur J Mol Biol Biochem 2016 3 101 106
    [Google Scholar]
  113. Ba Y. Malhotra A. Potential of piperine in modulation of voltage-gated K+ current and its influences on cell cycle arrest and apoptosis in human prostate cancer cells. Eur. Rev. Med. Pharmacol. Sci. 2018 22 24 8999 9011 10.26355/EURREV_201812_16671 30575945
    [Google Scholar]
  114. George K. Thomas N.S. Malathi R. Piperine blocks voltage gated K+ current and inhibits proliferation in androgen sensitive and insensitive human prostate cancer cell lines. Arch. Biochem. Biophys. 2019 667 36 48 10.1016/j.abb.2019.04.007 31047869
    [Google Scholar]
  115. Qi Y. Yao L. Liu J. Wang W. Piperine improves the sensitivity of osteosarcoma cells to doxorubicin by inducing apoptosis and inhibiting the PI3K/AKT/GSK-3β pathway. J. Orthop. Surg. Res. 2023 18 1 180 10.1186/s13018‑023‑03642‑7 36895009
    [Google Scholar]
  116. Prasad M. Jayaraman S. Natarajan S.R. Piperine modulates IR/Akt/GLUT4 pathways to mitigate insulin resistance: Evidence from animal and computational studies. Int. J. Biol. Macromol. 2023 253 Pt 5 127242 10.1016/j.ijbiomac.2023.127242 37797864
    [Google Scholar]
  117. Maeda A. Shirao T. Shirasaya D. Piperine promotes glucose uptake through ROS‐dependent activation of the CAMKK/AMPK signaling pathway in skeletal muscle. Mol. Nutr. Food Res. 2018 62 11 1800086 10.1002/mnfr.201800086 29683271
    [Google Scholar]
  118. Wang Y. Sun H. Zhang J. Xia Z. Chen W. Streptozotocin-induced diabetic cardiomyopathy in rats: Ameliorative effect of piperine via Bcl2, Bax/Bcl2, and caspase-3 pathways. Biosci. Biotechnol. Biochem. 2020 84 12 2533 2544 10.1080/09168451.2020.1815170 32892714
    [Google Scholar]
  119. Wang X. Zhang Y. Zhang L. Wang W. Che H. Zhang Y. Piperine attenuates hepatic steatosis and insulin resistance in high-fat diet-induced obesity in Sprague-Dawley rats. Nutr. Res. 2022 108 9 21 10.1016/j.nutres.2022.10.007 36375392
    [Google Scholar]
  120. Liu C. Yuan Y. Zhou J. Hu R. Ji L. Jiang G. Piperine ameliorates insulin resistance via inhibiting metabolic inflammation in monosodium glutamate-treated obese mice. BMC Endocr. Disord. 2020 20 1 152 10.1186/s12902‑020‑00617‑1 33028294
    [Google Scholar]
  121. Park U.H. Jeong H.S. Jo E.Y. Piperine, a component of black pepper, inhibits adipogenesis by antagonizing PPARγ activity in 3T3-L1 cells. J. Agric. Food Chem. 2012 60 15 3853 3860 10.1021/jf204514a 22463744
    [Google Scholar]
  122. Wang W. Zhang Y. Wang X. Che H. Zhang Y. Piperine improves obesity by inhibiting fatty acid absorption and repairing intestinal barrier function. Plant Foods Hum. Nutr. 2021 76 4 410 418 10.1007/s11130‑021‑00919‑2 34591253
    [Google Scholar]
  123. Dong Y. Huihui Z. Li C. Piperine inhibit inflammation, alveolar bone loss and collagen fibers breakdown in a rat periodontitis model. J. Periodontal Res. 2015 50 6 758 765 10.1111/jre.12262 25736698
    [Google Scholar]
  124. Zhai W. Zhang Z. Xu N. Piperine plays an anti‐inflammatory role in Staphylococcus aureus endometritis by inhibiting activation of NF‐κB and MAPK pathways in mice. Evid. Based Complement. Alternat. Med. 2016 2016 1 8597208 10.1155/2016/8597208 27293467
    [Google Scholar]
  125. Jaisin Y. Ratanachamnong P. Wongsawatkul O. Watthammawut A. Malaniyom K. Natewong S. Antioxidant and anti-inflammatory effects of piperine on UV-B-irradiated human HaCaT keratinocyte cells. Life Sci. 2020 263 118607 10.1016/j.lfs.2020.118607 33091445
    [Google Scholar]
  126. Li Y. Li K. Hu Y. Xu B. Zhao J. Piperine mediates LPS induced inflammatory and catabolic effects in rat intervertebral disc. Int. J. Clin. Exp. Pathol. 2015 8 6 6203 6213 [PMID: 26261497
    [Google Scholar]
  127. Wang-sheng C. Jie A. Jian-jun L. Lan H. Zeng-bao X. Chang-] qing L. Piperine attenuates lipopolysaccharide (LPS)-induced inflammatory responses in BV2 microglia. Int. Immunopharmacol. 2017 42 44 48 10.1016/j.intimp.2016.11.001 27875748
    [Google Scholar]
  128. Pei H. Xue L. Tang M. Alkaloids from black pepper (Piper nigrum L.) exhibit anti-inflammatory activity in murine macrophages by inhibiting activation of NF-κB pathway. J. Agric. Food Chem. 2020 68 8 2406 2417 10.1021/acs.jafc.9b07754 32031370
    [Google Scholar]
  129. Nasrnezhad R. Halalkhor S. Sadeghi F. Pourabdolhossein F. Piperine improves experimental autoimmune encephalomyelitis (EAE) in Lewis rats through its neuroprotective, anti-inflammatory, and antioxidant effects. Mol. Neurobiol. 2021 58 11 5473 5493 10.1007/s12035‑021‑02497‑5 34338970
    [Google Scholar]
  130. Bang J.S. Oh D.H. Choi H.M. Anti-inflammatory and antiarthritic effects of piperine in human interleukin 1β-stimulated fibroblast-like synoviocytes and in rat arthritis models. Arthritis Res. Ther. 2009 11 2 R49 10.1186/ar2662 19327174
    [Google Scholar]
  131. Jati G.A.K. Assihhah N. Wati A.A. Salasia S.I.O. Immunosuppression by piperine as a regulator of the NLRP3 inflammasome through MAPK/NF-κB in monosodium urate-induced rat gouty arthritis. Vet. World 2022 15 2 288 298 10.14202/vetworld.2022.288‑298 35400961
    [Google Scholar]
  132. Baito Q.N. Jaafar H.M. Mohammad T.A.M. Piperine suppresses inflammatory fibroblast-like synoviocytes derived from rheumatoid arthritis patients Via NF-κB inhibition. Cell. Immunol. 2023 391-392 104752 10.1016/j.cellimm.2023.104752 37536000
    [Google Scholar]
  133. Duan Z. Xie H. Yu S. Wang S. Yang H. Piperine derived from Piper nigrum L. inhibits LPS-induced inflammatory through the MAPK and NF-κB signalling pathways in RAW264.7 cells. Foods 2022 11 19 2990 10.3390/foods11192990 36230067
    [Google Scholar]
  134. Yu S Liu X Yu D e C Yang J Piperine protects LPS-induced mastitis by inhibiting inflammatory response. Int. Immunopharmacol. 2020 87 106804 10.1016/j.intimp.2020.106804 32707496
    [Google Scholar]
  135. Elkady A. Tawfik S. Anti-inflammatory role of piperine against rat lung tissue damage induced by gamma-rays. Int J Radiat Res 2018 16 75 84
    [Google Scholar]
  136. Duan Z. Yu S. Wang S. Protective effects of piperine on ethanol-induced gastric mucosa injury by oxidative stress inhibition. Nutrients 2022 14 22 4744 10.3390/nu14224744 36432431
    [Google Scholar]
  137. Peng X. Yang T. Liu G. Liu H. Peng Y. He L. Piperine ameliorated lupus nephritis by targeting AMPK-mediated activation of NLRP3 inflammasome. Int. Immunopharmacol. 2018 65 448 457 10.1016/j.intimp.2018.10.025 30388519
    [Google Scholar]
  138. Gervasoni K.N. Iacia M.V.M.D.S. Silva K.D.O. Protective effect of piperine on indomethacin-induced intestinal damage. Mol. Nutr. Food Res. 2025 69 12 70097 10.1002/mnfr.70097 40320901
    [Google Scholar]
  139. Hu Y. Wang Y. Gao H. Piperine improves DSS-induced colitis in mice via inhibition of inflammation and modulation of gut microbiota. Phytother. Res. 2025 39 7 3197 3211 10.1002/ptr.8491 40456559
    [Google Scholar]
  140. Huang J. Zhang T. Han S. Cao J. Chen Q. Wang S. The inhibitory effect of piperine from Fructus piperis extract on the degranulation of RBL-2H3 cells. Fitoterapia 2014 99 218 226 10.1016/j.fitote.2014.10.001 25307563
    [Google Scholar]
  141. Qiao C. Hu S. Che D. The anti‐anaphylactoid effects of Piperine through regulating MAS‐related G protein‐coupled receptor X2 activation. Phytother. Res. 2020 34 6 1409 1420 10.1002/ptr.6615 31989711
    [Google Scholar]
  142. Li H. Yu B. Lin J. Piperine inhibits fungal growth and protects against pyroptosis in Aspergillus fumigatus keratitis by regulating the mTOR/HIF-1α pathway. Int. Immunopharmacol. 2025 150 114286 10.1016/j.intimp.2025.114286 39954657
    [Google Scholar]
  143. Cai X. Bai Y. Liang C. Piperine as a promising therapeutic agent for silicosis: Targeting the JAK2-STAT3 signaling pathway and alleviating inflammation and fibrosis. Int. Immunopharmacol. 2025 153 114458 10.1016/j.intimp.2025.114458 40106900
    [Google Scholar]
  144. Liu Z. Hu Q. Wang W. Natural product piperine alleviates experimental allergic encephalomyelitis in mice by targeting dihydroorotate dehydrogenase. Biochem. Pharmacol. 2020 177 114000 10.1016/j.bcp.2020.114000 32353424
    [Google Scholar]
  145. Bernardo A.R. da Rocha J.D.B. de Lima M.E.F. Ricardo D.D. da Silva L.H.P. Peçanha L.M.T. Modulating effect of the piperine, the main alkaloid from Piper nigrum Linn., on murine B lymphocyte function. Braz J Vet Med 2015 37 209 216
    [Google Scholar]
  146. Kim S.H. Lee Y.C. Piperine inhibits eosinophil infiltration and airway hyperresponsiveness by suppressing T cell activity and Th2 cytokine production in the ovalbumin-induced asthma model. J. Pharm. Pharmacol. 2009 61 3 353 359 10.1211/jpp.61.03.0010 19222908
    [Google Scholar]
  147. Aldaly Z.T.K. Antimicrobial activity of piperine purified from Piper nigrum. J. Basrah Res. 2010 36 54 60
    [Google Scholar]
  148. Das S. Paul P. Chatterjee S. Piperine exhibits promising antibiofilm activity against Staphylococcus aureus by accumulating reactive oxygen species (ROS). Arch. Microbiol. 2022 204 1 59 10.1007/s00203‑021‑02642‑7 34940904
    [Google Scholar]
  149. Das S. Paul P. Dastidar D.G. Piperine exhibits potential antibiofilm activity against Pseudomonas aeruginosa by accumulating reactive oxygen species, affecting cell surface hydrophobicity and quorum sensing. Appl. Biochem. Biotechnol. 2023 195 5 3229 3256 10.1007/s12010‑022‑04280‑1 36580259
    [Google Scholar]
  150. Priya A. Pandian S.K. Piperine impedes biofilm formation and hyphal morphogenesis of Candida albicans. Front. Microbiol. 2020 11 756 10.3389/fmicb.2020.00756 32477284
    [Google Scholar]
  151. Choudhary P. Chakdar H. Singh D. Computational studies reveal piperine, the predominant oleoresin of black pepper (Piper nigrum) as a potential inhibitor of SARS-CoV-2 (COVID-19). Curr. Sci. 2020 119 8 1333 10.18520/cs/v119/i8/1333‑1342
    [Google Scholar]
  152. Askari G. Sahebkar A. Soleimani D. The efficacy of curcumin-piperine co-supplementation on clinical symptoms, duration, severity, and inflammatory factors in COVID-19 outpatients: A randomized double-blind, placebo-controlled trial. Trials 2022 23 1 472 10.1186/s13063‑022‑06375‑w 35668500
    [Google Scholar]
  153. Askari G. Bagherniya M. Kiani Z. Evaluation of curcumin-piperine supplementation in COVID-19 patients admitted to the intensive care: A double-blind, randomized controlled trial. Adv. Exp. Med. Biol. 2023 1412 413 426 10.1007/978‑3‑031‑28012‑2_22 37378780
    [Google Scholar]
  154. Pawar K.S. Mastud R.N. Pawar S.K. Oral curcumin with piperine as adjuvant therapy for the treatment of covid-19: A randomized clinical trial. Front. Pharmacol. 2021 12 669362 10.3389/fphar.2021.669362 34122090
    [Google Scholar]
  155. Nouri-Vaskeh M. Hashemi P. Hataminia N. Yazdani Y. Nasirian M. Alizadeh L. The impact of piperine on the metabolic conditions of patients with NAFLD and early cirrhosis: A randomized double-blind controlled trial. Sci. Rep. 2024 14 1 1053 10.1038/s41598‑024‑51726‑z 38200253
    [Google Scholar]
  156. Panahi Y. Valizadegan G. Ahamdi N. Ganjali S. Majeed M. Sahebkar A. Curcuminoids plus piperine improve nonalcoholic fatty liver disease: A clinical trial. J. Cell. Biochem. 2019 120 9 15989 15996 10.1002/jcb.28877 31168845
    [Google Scholar]
  157. Mirhafez S.R. Farimani A.R. Gholami A. The effect of curcumin with piperine supplementation on pro-oxidant and antioxidant balance in patients with non-alcoholic fatty liver disease: A randomized, double-blind, placebo-controlled trial. Drug Metab. Pers. Ther. 2019 34 2 10.1515/dmpt‑2018‑0040 31145689
    [Google Scholar]
  158. Ali Hosseinian S. Reza Mirhafez S. Mehrzad J. Saeedi J. Zhiyani R. Hossein Sahebkar A. Effects of curcumin plus piperine on oxidative stress markers in patients with non-alcoholic fatty liver disease: A randomized double-blind placebo-controlled trial. Int Med Today 2022 29 64 72 10.32592/IMTJ.2023.29.1.64
    [Google Scholar]
  159. Sharifi S. Bagherniya M. Khoram Z. Efficacy of curcumin plus piperine co‐supplementation in moderate‐to‐high hepatic steatosis: A double‐blind, randomized, placebo‐controlled clinical trial. Phytother. Res. 2023 37 6 2217 2229 10.1002/ptr.7764 36799355
    [Google Scholar]
  160. Neta J.F.F. Veras V.S. Sousa D.F. Effectiveness of the piperine-supplemented Curcuma longa L. in metabolic control of patients with type 2 diabetes: A randomised double-blind placebo-controlled clinical trial. Int. J. Food Sci. Nutr. 2021 72 7 968 977 10.1080/09637486.2021.1885015 33586583
    [Google Scholar]
  161. Panahi Y. Khalili N. Sahebi E. Curcuminoids plus piperine modulate adipokines in type 2 diabetes mellitus. Curr. Clin. Pharmacol. 2018 12 4 253 258 10.2174/1574884713666180104095641 29299989
    [Google Scholar]
  162. Panahi Y. Khalili N. Sahebi E. Effects of curcuminoids plus piperine on glycemic, hepatic and inflammatory biomarkers in patients with type 2 diabetes mellitus: A randomized double-blind placebo-controlled trial. Drug Res. 2018 68 7 403 409 10.1055/s‑0044‑101752 29458218
    [Google Scholar]
  163. Heidari-Beni M. Moravejolahkami A.R. Gorgian P. Askari G. Tarrahi M.J. Bahreini-Esfahani N. Herbal formulation “turmeric extract, black pepper, and ginger” versus Naproxen for chronic knee osteoarthritis: A randomized, double‐blind, controlled clinical trial. Phytother. Res. 2020 34 8 2067 2073 10.1002/ptr.6671 32180294
    [Google Scholar]
  164. Rahimnia A.R. Panahi Y. Alishiri G. Sharafi M. Sahebkar A. Impact of supplementation with curcuminoids on systemic inflammation in patients with knee osteoarthritis: Findings from a randomized double-blind placebo-controlled trial. Drug Res. 2014 65 10 521 525 10.1055/s‑0034‑1384536 25050518
    [Google Scholar]
  165. Shafiee A. Hoormand M. Shahidi-Dadras M. Abadi A. The effect of topical piperine combined with narrowband UVB on vitiligo treatment: A clinical trial study. Phytother. Res. 2018 32 9 1812 1817 10.1002/ptr.6116 29781089
    [Google Scholar]
  166. Patel N. Jagannath K. Vora A. Patel M. Patel A. A randomized, controlled, phase III clinical trial to evaluate the efficacy and tolerability of risorine with conventional rifampicin in the treatment of newly diagnosed. J. Assoc. Physicians India 2017 65 9 48 54 10.5555/20183063838 29313577
    [Google Scholar]
  167. Gilardini L. Pasqualinotto L. Di Pierro F. Risso P. Invitti C. Effects of Greenselect Phytosome® on weight maintenance after weight loss in obese women: A randomized placebo-controlled study. BMC Complement. Altern. Med. 2016 16 1 233 10.1186/s12906‑016‑1214‑x 27450231
    [Google Scholar]
  168. Panahi Y. Ghanei M. Hajhashemi A. Sahebkar A. Effects of curcuminoids-piperine combination on systemic oxidative stress, clinical symptoms and quality of life in subjects with chronic pulmonary complications due to sulfur mustard: A randomized controlled trial. J. Diet. Suppl. 2016 13 1 93 105 10.3109/19390211.2014.952865 25171552
    [Google Scholar]
  169. Polley K.R. Jenkins N. O’Connor P. McCully K. Influence of exercise training with resveratrol supplementation on skeletal muscle mitochondrial capacity. Appl. Physiol. Nutr. Metab. 2016 41 1 26 32 10.1139/apnm‑2015‑0370 26638911
    [Google Scholar]
  170. Panahi Y. Badeli R. Karami G.R. Sahebkar A. Investigation of the efficacy of adjunctive therapy with bioavailability-boosted curcuminoids in major depressive disorder. Phytother. Res. 2015 29 1 17 21 10.1002/ptr.5211 25091591
    [Google Scholar]
  171. Panahi Y. Khalili N. Hosseini M.S. Abbasinazari M. Sahebkar A. Lipid-modifying effects of adjunctive therapy with curcuminoids-piperine combination in patients with metabolic syndrome: Results of a randomized controlled trial. Complement. Ther. Med. 2014 22 5 851 857 10.1016/j.ctim.2014.07.006 25440375
    [Google Scholar]
  172. Panahi Y. Hosseini M.S. Khalili N. Naimi E. Majeed M. Sahebkar A. Antioxidant and anti-inflammatory effects of curcuminoid-piperine combination in subjects with metabolic syndrome: A randomized controlled trial and an updated meta-analysis. Clin. Nutr. 2015 34 6 1101 1108 10.1016/j.clnu.2014.12.019 25618800
    [Google Scholar]
  173. Pastor R.F. Repetto M.G. Lairion F. Supplementation with resveratrol, piperine and alpha-tocopherol decreases chronic inflammation in a cluster of older adults with metabolic syndrome. Nutrients 2020 12 10 3149 10.3390/nu12103149 33076345
    [Google Scholar]
  174. Rofes L. Arreola V. Martin A. Clavé P. Effect of oral piperine on the swallow response of patients with oropharyngeal dysphagia. J. Gastroenterol. 2014 49 12 1517 1523 10.1007/s00535‑013‑0920‑0 24326980
    [Google Scholar]
  175. Boshagh K. Khorvash F. Sahebkar A. The effects of curcumin-piperine supplementation on inflammatory, oxidative stress and metabolic indices in patients with ischemic stroke in the rehabilitation phase: A randomized controlled trial. Nutr. J. 2023 22 1 69 10.1186/s12937‑023‑00905‑1 38082237
    [Google Scholar]
  176. kotb RR Afifi AM EL-Houseini ME The potential immunostimulating effect of curcumin, piperine, and taurine combination in hepatocellular carcinoma; a pilot study. Discover Oncology 2023 14 1 169 10.1007/s12672‑023‑00785‑1 37704828
    [Google Scholar]
  177. Hatab H.M. Abdel Hamid F.F. Soliman A.F. Al-Shafie T.A. Ismail Y.M. El-Houseini M.E. A combined treatment of curcumin, piperine, and taurine alters the circulating levels of IL-10 and miR-21 in hepatocellular carcinoma patients: A pilot study. J. Gastrointest. Oncol. 2019 10 4 766 776 10.21037/jgo.2019.03.07 31392057
    [Google Scholar]
  178. Martins A.S.P. Araújo O.R.P. Gomes A.S. Effect of curcumin plus piperine on redox imbalance, fecal calprotectin and cytokine levels in inflammatory bowel disease patients: A randomized, double-blind, placebo-controlled clinical trial. Pharmaceuticals 2024 17 7 849 10.3390/ph17070849 39065700
    [Google Scholar]
  179. da Paz Martins A.S. de Araújo O.R.P. da Silva Gomes A. Curcumin plus piperine improve body composition in patients with inflammatory bowel disease: A randomized, double-blind, placebo-controlled clinical trial. Eur. J. Nutr. 2025 64 2 90 10.1007/s00394‑025‑03608‑x 39934549
    [Google Scholar]
  180. Bahrami A. Mohammadifard M. Rajabi Z. Motahari-Nasab M. Ferns G.A. Effects of curcumin-piperine supplementation on systemic immunity in young women with premenstrual syndrome and dysmenorrhea: A randomized clinical trial. Eur. J. Obstet. Gynecol. Reprod. Biol. 2022 278 131 136 10.1016/j.ejogrb.2022.09.021 36174434
    [Google Scholar]
  181. Karbasi S. Seyedabadi S. Mozaffari S. Curcuminoid-piperine combination improves radical scavenging activity in women with premenstrual syndrome and dysmenorrhea: A post-hoc analysis of a randomized clinical study. Chonnam Med. J. 2024 60 2 113 119 10.4068/cmj.2024.60.2.113 38841613
    [Google Scholar]
  182. Tabaee S. Sahebkar A. Aghamohammadi T. The effects of curcumin plus piperine supplementation in patients with acute myocardial infarction: A randomized, double-blind, and placebo-controlled trial. Adv. Exp. Med. Biol. 2021 1328 199 211 10.1007/978‑3‑030‑73234‑9_13 34981479
    [Google Scholar]
  183. Alikiaii B. Khatib N. Badpeyma M. Therapeutic effects of curcumin and piperine combination in critically ill patients with sepsis: A randomized double-blind controlled trial. Trials 2025 26 1 205 10.1186/s13063‑025‑08916‑5 40514680
    [Google Scholar]
  184. Arora S. Singh B. Kumar S. Kumar A. Singh A. Singh C. Piperine loaded drug delivery systems for improved biomedical applications: Current status and future directions. Health Sci. Rep. 2023 9 100138 10.1016/j.hsr.2023.100138
    [Google Scholar]
  185. Salsabila H. Fitriani L. Zaini E. Recent strategies for improving solubility and oral bioavailability of piperine. Inter J Appl Pharm 2021 13 31 39 10.22159/ijap.2021v13i4.41596
    [Google Scholar]
  186. Dubey S.K. Parab S. Achalla V.P.K. Microparticulate and nanotechnology mediated drug delivery system for the delivery of herbal extracts. J. Biomater. Sci. Polym. Ed. 2022 33 12 1531 1554 10.1080/09205063.2022.2065408 35404217
    [Google Scholar]
  187. Patra J.K. Das G. Fraceto L.F. Nano based drug delivery systems: Recent developments and future prospects. J. Nanobiotechnology 2018 16 1 71 10.1186/s12951‑018‑0392‑8 30231877
    [Google Scholar]
  188. Sharma G. Panwar R. Saini S. Tuli H.S. Wadhwa K. Pahwa R. Emerging phytochemical-based nanocarriers: Redefining the perspectives of breast cancer therapy. Naunyn Schmiedebergs Arch. Pharmacol. 2025 398 11199 11227 10.1007/s00210‑025‑04003‑3 40137964
    [Google Scholar]
  189. Wadhwa K. Kadian V. Puri V. New insights into quercetin nanoformulations for topical delivery. Phytomedicine Plus 2022 2 2 100257 10.1016/j.phyplu.2022.100257
    [Google Scholar]
  190. Dewi M.K. Chaerunisaa A.Y. Muhaimin M. Joni I.M. Improved activity of herbal medicines through nanotechnology. Nanomaterials 2022 12 22 4073 10.3390/nano12224073 36432358
    [Google Scholar]
  191. Pachauri M. Gupta E.D. Ghosh P.C. Piperine loaded PEG-PLGA nanoparticles: Preparation, characterization and targeted delivery for adjuvant breast cancer chemotherapy. J. Drug Deliv. Sci. Technol. 2015 29 269 282 10.1016/j.jddst.2015.08.009
    [Google Scholar]
  192. Wang Y. Huang X. Chen H. The antitumour activity of a curcumin and piperine loaded iRGD-modified liposome: In vitro and in vivo evaluation. Molecules 2023 28 18 6532 10.3390/molecules28186532 37764308
    [Google Scholar]
  193. Ding Y. Wang C. Wang Y. Development and evaluation of a novel drug delivery: Soluplus ® /TPGS mixed micelles loaded with piperine in vitro and in vivo. Drug Dev. Ind. Pharm. 2018 44 9 1409 1416 10.1080/03639045.2018.1472277 29718714
    [Google Scholar]
  194. Javed B. Zhao X. Cui D. Curtin J. Tian F. Enhanced anticancer response of curcumin-and piperine-loaded lignin-g-p (Nipam-co-dmaema) gold nanogels against u-251 mg glioblastoma multiforme. Biomedicines 2021 9 11 1516 10.3390/biomedicines9111516 34829745
    [Google Scholar]
  195. Zafar F. Jahan N. Bhatti H. Increased oral bioavailability of piperine from an optimized piper nigrum nanosuspension. Planta Med. 2019 85 3 249 257 10.1055/a‑0759‑2208 30357764
    [Google Scholar]
  196. Ozkan B. Altuntas E. Cakir Koc R. Budama-Kilinc Y. Development of piperine nanoemulsions: An alternative topical application for hypopigmentation. Drug Dev. Ind. Pharm. 2022 48 3 117 127 10.1080/03639045.2022.2100901 35815814
    [Google Scholar]
  197. Kazi M. Shahba A.A. Alrashoud S. Alwadei M. Sherif A.Y. Alanazi F.K. Bioactive self-nanoemulsifying drug delivery systems (Bio-SNEDDS) for combined oral delivery of curcumin and piperine. Molecules 2020 25 7 1703 10.3390/molecules25071703 32276393
    [Google Scholar]
  198. Milligan J.J. Saha S. A nanoparticle’s journey to the tumor: Strategies to overcome first-pass metabolism and their limitations. Cancers 2022 14 7 1741 10.3390/cancers14071741 35406513
    [Google Scholar]
  199. Rajput A. Pingale P. Telange D. Chalikwar S. Borse V. Lymphatic transport system to circumvent hepatic metabolism for oral delivery of lipid-based nanocarriers. J. Drug Deliv. Sci. Technol. 2021 66 102934 10.1016/j.jddst.2021.102934
    [Google Scholar]
  200. Kirtane A.R. Kalscheuer S.M. Panyam J. Exploiting nanotechnology to overcome tumor drug resistance: Challenges and opportunities. Adv. Drug Deliv. Rev. 2013 65 13-14 1731 1747 10.1016/j.addr.2013.09.001
    [Google Scholar]
  201. Lu R. Zhou Y. Ma J. Wang Y. Miao X. Strategies and mechanism in reversing intestinal drug efflux in oral drug delivery. Pharmaceutics 2022 14 6 1131 10.3390/pharmaceutics14061131 35745704
    [Google Scholar]
  202. Kazmi I. Al-Abbasi F.A. Imam S.S. Formulation of piperine nanoparticles: In vitro breast cancer cell line and in vivo evaluation. Polymers 2022 14 7 1349 10.3390/polym14071349 35406223
    [Google Scholar]
  203. Vitor L.C. Di Filippo L.D. Duarte J.L. Characterization and in vitro cytotoxicity of piperine-loaded nanoemulsion in breast cancer cells. Chem. Zvesti 2024 78 4 2577 2587 10.1007/s11696‑023‑03262‑9
    [Google Scholar]
  204. Alshehri S. Bukhari S.I. Imam S.S. Formulation of piperine-loaded nanoemulsion: In vitro characterization, ex vivo evaluation, and cell viability assessment. ACS Omega 2023 8 25 22406 22413 10.1021/acsomega.2c08187 37396261
    [Google Scholar]
  205. Zafar A. Alruwaili N.K. Imam S.S. Formulation of chitosan-coated piperine NLCs: Optimization, in vitro characterization, and in vivo preclinical assessment. AAPS PharmSciTech 2021 22 7 231 10.1208/s12249‑021‑02098‑4 34477999
    [Google Scholar]
  206. Darwish A.B. Mohsen A.M. ElShebiney S. Elgohary R. Younis M.M. Development of chitosan lipid nanoparticles to alleviate the pharmacological activity of piperine in the management of cognitive deficit in diabetic rats. Sci. Rep. 2024 14 1 8247 10.1038/s41598‑024‑58601‑x 38589438
    [Google Scholar]
  207. Bhalekar M.R. Madgulkar A.R. Desale P.S. Marium G. Formulation of piperine solid lipid nanoparticles (SLN) for treatment of rheumatoid arthritis. Drug Dev. Ind. Pharm. 2017 43 6 1003 1010 10.1080/03639045.2017.1291666 28161984
    [Google Scholar]
  208. Imam S.S. Alshehri S. Altamimi M.A. Formulation of piperine-chitosan-coated liposomes: Characterization and in vitro cytotoxic evaluation. Molecules 2021 26 11 3281 10.3390/molecules26113281 34072306
    [Google Scholar]
  209. Ahmad S. Hafeez A. Formulation and development of curcumin-piperine-loaded S-SNEDDS for the treatment of Alzheimer’s disease. Mol. Neurobiol. 2023 60 2 1067 1082 10.1007/s12035‑022‑03089‑7 36414909
    [Google Scholar]
  210. Eltaib L. Polymeric nanoparticles in targeted drug delivery: Unveiling the impact of polymer characterization and fabrication. Polymers 2025 17 7 833 10.3390/polym17070833 40219222
    [Google Scholar]
  211. Sabourian P. Yazdani G. Ashraf S.S. Effect of physico-chemical properties of nanoparticles on their intracellular uptake. Int. J. Mol. Sci. 2020 21 21 8019 10.3390/ijms21218019 33126533
    [Google Scholar]
  212. Filli M.S. Ibrahim A.A. Aquib M. The impact of physicochemical characteristics on therapeutic efficacy of anticancer nanomaterials: A review. Int. J. Pharm. Sci. Drug Res. 2019 11 61 70 10.25004/IJPSDR.2019.110203
    [Google Scholar]
  213. Danaei M. Dehghankhold M. Ataei S. Impact of particle size and polydispersity index on the clinical applications of lipidic nanocarrier systems. Pharmaceutics 2018 10 2 57 10.3390/pharmaceutics10020057 29783687
    [Google Scholar]
  214. Yusuf M. Khan M. Khan R.A. Ahmed B. Preparation, characterization, in vivo and biochemical evaluation of brain targeted Piperine solid lipid nanoparticles in an experimentally induced Alzheimer’s disease model. J. Drug Target. 2013 21 3 300 311 10.3109/1061186X.2012.747529 23231324
    [Google Scholar]
  215. Patel C.M. Patel M.A. Patel N.P. Patel C.N. Poly lactic glycolic acid (PLGA) as biodegradable polymer. Res J Pharm Technol 2010 3 2 353 360
    [Google Scholar]
  216. Zafar A. Imam S.S. Alruwaili N.K. Development of piperine-loaded solid self-nanoemulsifying drug delivery system: Optimization, in-vitro, ex-vivo, and in-vivo evaluation. Nanomaterials 2021 11 11 2920 10.3390/nano11112920 34835684
    [Google Scholar]
  217. Francis R. Parthasarathy S. Aly S.H. Development of novel piperine-loaded mesoporous silica nanoparticles: Enhanced drug delivery and comprehensive in vivo safety analysis. Chem. Biodivers. 2025 22 6 202401901 10.1002/cbdv.202401901 39889209
    [Google Scholar]
  218. Paliwal R. Babu R.J. Palakurthi S. Nanomedicine scale-up technologies: Feasibilities and challenges. AAPS PharmSciTech 2014 15 6 1527 1534 10.1208/s12249‑014‑0177‑9 25047256
    [Google Scholar]
  219. Wu L. Zhang J. Watanabe W. Physical and chemical stability of drug nanoparticles. Adv. Drug Deliv. Rev. 2011 63 6 456 469 10.1016/j.addr.2011.02.001 21315781
    [Google Scholar]
  220. Sultana S. Alzahrani N. Alzahrani R. Stability issues and approaches to stabilised nanoparticles based drug delivery system. J. Drug Target. 2020 28 5 468 486 10.1080/1061186X.2020.1722137 31984810
    [Google Scholar]
  221. Sharma S. Parveen R. Chatterji B.P. Toxicology of nanoparticles in drug delivery. Curr. Pathobiol. Rep. 2021 9 4 133 144 10.1007/s40139‑021‑00227‑z 34840918
    [Google Scholar]
  222. Ramakrishna D. Rao P. Nanoparticles: Is toxicity a concern? EJIFCC 2011 22 4 92 101 [PMID: 27683397
    [Google Scholar]
  223. Hua S. de Matos M.B.C. Metselaar J.M. Storm G. Current trends and challenges in the clinical translation of nanoparticulate nanomedicines: Pathways for translational development and commercialization. Front. Pharmacol. 2018 9 790 10.3389/fphar.2018.00790 30065653
    [Google Scholar]
  224. AbouAitah K. Stefanek A. Higazy I.M. Effective targeting of colon cancer cells with piperine natural anticancer prodrug using functionalized clusters of hydroxyapatite nanoparticles. Pharmaceutics 2020 12 1 70 10.3390/pharmaceutics12010070 31963155
    [Google Scholar]
  225. Elnaggar Y.S.R. Etman S.M. Abdelmonsif D.A. Abdallah O.Y. Intranasal piperine-loaded chitosan nanoparticles as brain-targeted therapy in Alzheimer’s disease: Optimization, biological efficacy, and potential toxicity. J. Pharm. Sci. 2015 104 10 3544 3556 10.1002/jps.24557
    [Google Scholar]
  226. Ren T. Hu M. Cheng Y. Piperine-loaded nanoparticles with enhanced dissolution and oral bioavailability for epilepsy control. Eur. J. Pharm. Sci. 2019 137 104988 10.1016/j.ejps.2019.104988 31291598
    [Google Scholar]
  227. Li J. Leung S.S.Y. Chan E.H.Y. Jiang C. Ho E.T.Y. Zuo Z. Significantly increased aqueous solubility of piperine via nanoparticle formulation serves as the most critical factor for its brain uptake enhancement. Int. J. Nanomedicine 2025 20 3945 3959 10.2147/IJN.S506827 40181831
    [Google Scholar]
  228. Tang B. Sun J. Xiao J. Development of piperine nanoparticles stabilized by OSA modified starch through wet-media milling technique with enhanced anti-adipogenic effect in 3T3-L1 adipocytes. Int. J. Biol. Macromol. 2024 272 Pt 1 132738 10.1016/j.ijbiomac.2024.132738 38825269
    [Google Scholar]
  229. Risangud N. Jangpromma N. Kunnaja P. Enhancing the therapeutic efficacy of piperine in colorectal cancer: Development and evaluation of piperine-loaded PLGA-b-PEG copolymer nanoparticles. Eur. J. Pharm. Biopharm. 2025 214 114796 10.1016/j.ejpb.2025.114796 40553907
    [Google Scholar]
  230. Kaur J. Singh R.R. Khan E. Kumar A. Joshi A. Piperine-loaded PLGA nanoparticles as cancer drug carriers. ACS Appl. Nano Mater. 2021 4 12 14197 14207 10.1021/acsanm.1c03664
    [Google Scholar]
  231. Rad J.G. Hoskin D.W. Delivery of apoptosis-inducing piperine to triple-negative breast cancer cells co-polymeric nanoparticles. Anticancer Res. 2020 40 2 689 694 10.21873/anticanres.13998 32014909
    [Google Scholar]
  232. Baspinar Y. Üstündas M. Bayraktar O. Sezgin C. Curcumin and piperine loaded zein-chitosan nanoparticles: Development and in-vitro characterisation. Saudi Pharm. J. 2018 26 3 323 334 10.1016/j.jsps.2018.01.010 29556123
    [Google Scholar]
  233. El-Raghi A.A. Elmorsy E.M. Hassan M.A.E. Effects of piperine-loaded chitosan nanoparticles on growth and health of heat-stressed rabbits: A dose-response analysis. Ital. J. Anim. Sci. 2025 24 1 1655 1671 10.1080/1828051X.2025.2540003
    [Google Scholar]
  234. Srivastav S. Anand B.G. Fatima M. Piperine-coated gold nanoparticles alleviate paraquat-induced neurotoxicity in Drosophila melanogaster. ACS Chem. Neurosci. 2020 11 22 3772 3785 10.1021/acschemneuro.0c00366 33125229
    [Google Scholar]
  235. Shaik M.R. Kandaswamy K. Guru A. Piperine-coated zinc oxide nanoparticles target biofilms and induce oral cancer apoptosis via BCl-2/BAX/P53 pathway. BMC Oral Health 2024 24 1 715 10.1186/s12903‑024‑04399‑z 38907185
    [Google Scholar]
  236. Unni V. Abishad P. Mohan B. Antibacterial and photocatalytic potential of piperine-derived zinc oxide nanoparticles against multi-drug-resistant non-typhoidal Salmonella spp. BMC Microbiol. 2025 25 1 89 10.1186/s12866‑025‑03829‑4 40000999
    [Google Scholar]
  237. Sahebi K. Takallu S. Foroozand H. Piperine-loaded mesoporous silica nanoparticles as a promising strategy for targeting Echinococcus granulosus protoscoleces. Sci. Rep. 2025 15 1 520 10.1038/s41598‑024‑84131‑7 39747961
    [Google Scholar]
  238. Chaudhari V.S. Gawali B. Saha P. Naidu V.G.M. Murty U.S. Banerjee S. Quercetin and piperine enriched nanostructured lipid carriers (NLCs) to improve apoptosis in oral squamous cellular carcinoma (FaDu cells) with improved biodistribution profile. Eur. J. Pharmacol. 2021 909 174400 10.1016/j.ejphar.2021.174400 34332920
    [Google Scholar]
  239. Shehata E.M.M. Gowayed M.A. El-Ganainy S.O. Sheta E. Elnaggar Y.S.R. Abdallah O.Y. Pectin coated nanostructured lipid carriers for targeted piperine delivery to hepatocellular carcinoma. Int. J. Pharm. 2022 619 121712 10.1016/j.ijpharm.2022.121712 35367582
    [Google Scholar]
  240. Kumar P. Sharma D.K. Ashawat M.S. Topical creams of piperine loaded lipid nanocarriers for management of atopic dermatitis: Development, characterization, and in vivo investigation using BALB/c mice model. J. Liposome Res. 2022 32 1 62 73 10.1080/08982104.2021.1880436 33944670
    [Google Scholar]
  241. Yang Z. Pu M. Dong X. Ji F. Priya Veeraraghavan V. Yang H. Piperine loaded zinc oxide nanocomposite inhibits the PI3K/AKT/] mTOR signaling pathway via attenuating the development of gastric carcinoma: In vitro and in vivo studies. Arab. J. Chem. 2020 13 5 5501 5516 10.1016/j.arabjc.2020.03.028
    [Google Scholar]
  242. Adisuri D.S. Madhavan P. Chong P.P. Nathan S. Antifungal activity of piperine-based nanoemulsion against Candida spp. Via in vitro broth microdilution assay. J. Pharm. Sci. 2024 113 9 2843 2850 10.1016/j.xphs.2024.06.024 39004416
    [Google Scholar]
  243. Lima A.S. Prophiro J.S. Zepon K.M. Polycaprolactone triol-based polyurethane nanocapsules: High-efficiency encapsulation and sustained release of piperine with enhanced compatibility. Polym. Bull. 2025 82 5 1685 1704 10.1007/s00289‑024‑05598‑y
    [Google Scholar]
  244. Mudhol S. Serva Peddha M. Piperine-loaded sodium caseinate nanoglobules delivered transdermally through microneedle patch for improved bioavailability at adipose tissue. J. Appl. Polym. Sci. 2025 142 7 56499 10.1002/app.56499
    [Google Scholar]
  245. Kazi M. Khan M.F. Nasr F.A. Development of curcumin and piperine-loaded bio-active self-nanoemulsifying drugs and investigation of their bioactivity in zebrafish embryos and human hematological cancer cell lines. Int. J. Nanomedicine 2023 18 1793 1808 10.2147/IJN.S400330 37051315
    [Google Scholar]
/content/journals/cnanom/10.2174/0124681873431538251104034810
Loading
Unlocking the Therapeutic Potential of Piperine - From Ethnopharmacology to Nanodelivery Strategies
Bentham Science Publishers ; https://doi.org/10.2174/0124681873431538251104034810
/content/journals/cnanom/10.2174/0124681873431538251104034810
/content/journals/cnanom/10.2174/0124681873431538251104034810
Loading

Data & Media loading...


  • Article Type:     Review Article
Keywords: antioxidant ; pharmacological profile ; nanoformulations ; clinical studies ; Piperine ; anti-inflammatory

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test